Development of novel RHO kinase inhibitors for treatment of pulmonary hypertension

Ended Cooperative Agreement Awarded Last action

Award ID
W81XWH1420174
Recipient
Awarding agency
Obligated
$519,575

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Palo Alto, CA 94303, USA

Award details come from USAspending.gov.

Quick answers

Who received award W81XWH1420174?

W81XWH1420174 was awarded to Anacor Pharmaceuticals, Inc. by Department of Defense on September 30, 2014.

How much is award W81XWH1420174 worth?

$519,575 has been obligated on W81XWH1420174.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login